Placeholder Banner

BIO Statement on U.S.-China Comprehensive Economic Dialogue

May 12, 2017

“The Biotechnology Innovation Organization welcomes news of the U.S.-China agreement on initial results of the 100-day Action Plan of the U.S.-China Comprehensive Economic Dialogue,” said Joseph Damond, Executive Vice President for International Affairs.  “The agreement marks an important first step in the 100-day plan and towards broader engagement through the newly formed U.S.-China Comprehensive Economic Dialogue.” 

“Considering the history of this issue, the ultimate test of success will be for China to follow its process and quickly approve the eight pending biotechnology applications and establish a synchronized, timely and predictable process going forward,” added Damond.  “BIO will continue to engage through this process to monitor the implementation of the agreement.”  

Discover More
The Biotechnology Innovation Organization (BIO) today announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds. Announcing the new vision, mission and…
Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), today applauded the Food and Drug Administration (FDA) for publicly releasing new guidance related to the emergency use authorization of future…
The Biotechnology Innovation Organization (BIO) announced today the retirement of Senior Vice President and Chief Financial Officer (CFO), Yvette White-Wiggins, after a distinguished 18-year career with the organization. White-Wiggins rose through…